SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-011382
Filing Date
2022-04-28
Accepted
2022-04-28 08:15:14
Documents
14
Period of Report
2022-04-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36071
2 ex99-1.htm EX-99.1 279017
3 ex99-1_001.jpg GRAPHIC 2543
  Complete submission text file 0001493152-22-011382.txt   503569

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE mslp-20220414.xsd EX-101.SCH 3042
5 XBRL LABEL FILE mslp-20220414_lab.xml EX-101.LAB 34476
6 XBRL PRESENTATION FILE mslp-20220414_pre.xml EX-101.PRE 22601
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3178
Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Filer) CIK: 0001415684 (see all company filings)

IRS No.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53166 | Film No.: 22862361
SIC: 2834 Pharmaceutical Preparations